Timothy Bumann, DO
Undersea and Hyperbaric Medicine · Abilene, TXNPI 1306934435
Payments from drug & device makers
Across 521 payments — averaging $294.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$142K
- Tactile Systems Technology Inc$7K
- Kerecis Limited$2K
- Cashflow Solutions, LLC$561
- AbbVie$406
- Smith+Nephew$175
- plus $587 from 9 others
What the payments were for
- Consulting fees$18,42512%
- Speaking & faculty fees$114,80575%
- Travel & lodging$12,3838%
- Food & beverage$7,8525%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 321 | $142,264 |
| Tactile Systems Technology Inc | 97 | $7,203 |
| Kerecis Limited | 13 | $2,368 |
| Cashflow Solutions, LLC | 37 | $561 |
| AbbVie | 17 | $406 |
| Smith+Nephew | 10 | $175 |
| Urgo Medical North America, LLC | 3 | $152 |
| Convatec Inc. | 6 | $113 |
| KCI USA, Inc. | 5 | $100 |
| Molnlycke Health Care US, LLC | 3 | $57 |
| Celularity Inc. | 2 | $47 |
| Melinta Therapeutics, LLC | 2 | $42 |
| Solventum Corporation | 2 | $34 |
| Coloplast | 2 | $30 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$69,190
- Dermagraft$69,067
- Puraply/Affinity/NuTech$69,067
- PuraPly$32,501
- Puraply Antimicrobial$18,202
- Affinity$13,971
- Kerecis SurgiClose$7,892
- ENTRE$5,524
- FLEXITOUCH$5,390
- ACTITOUCH$5,390
- NuShield$1,978
- Kerecis GraftGuide$1,973
- Kerecis Omega3 Marigen$1,169
- Kerecis Omega3 SurgiClose$292
- Flexitouch Plus$134
How this compares
$153,565 in reported general payments places this provider in the 95th percentile of 59 undersea and hyperbaric medicine providers in Texas.
See all undersea and hyperbaric medicine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 21 | $185 |
| Ciprofloxacin Hcl | 14 | $124 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $51 |
| Levofloxacin | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Abilene
- Wade FarrowCollege Station$2.2M
- Marcus GitterleNew Braunfels$234K
- Heather AguirreSan Antonio$98K
- Ronald ScottFrisco$76K
- Andrew ApplewhiteDallas$46K
- Joseph WolcottLubbock$38K
- Noel OliveiraEdinburg$33K
- Maria AguinagaMission$18K
- Jayesh ShahSan Antonio$17K
- Caroline FifeThe Woodlands$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.